ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

ASCO Annual Meeting Abstracts Posted Online

May 28, 2010

Gene Variant Associated With 44 Percent Cancer Risk Reduction

October 26, 2012

In Brief: ACCC Lobbyists Got What They Wanted In House Cancer Act Bill; VA Group Review Set May 2

April 28, 1978

Early ADT Doesn’t Offer Survival Advantage—ASCO

April 27, 2007

In Brief: Nominations Open For Bristol-Myers Award; New Surgical Oncology Chair At South Florida

September 7, 1984

Controversy Continues, Scientists, Advocates, Clinicians Say

January 31, 1997